Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,408 | -84,100 | -44,255 | -128,724 | -102,311 |
| Depreciation Amortization | -5,595 | -3,194 | -1,598 | -172 | 945 |
| Accounts receivable | -1,850 | -1,763 | -104 | -543 | -304 |
| Other Working Capital | 2,333 | 11,336 | 8,089 | 6,839 | 930 |
| Other Operating Activity | 40,069 | 27,744 | 13,300 | 49,007 | 37,832 |
| Operating Cash Flow | $-86,451 | $-49,977 | $-24,568 | $-73,593 | $-62,908 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -527 | -365 | -175 | -358 | -183 |
| Purchase Of Investment | -237,612 | -167,564 | -48,555 | -802,503 | -674,925 |
| Sale Of Investment | 333,715 | 232,870 | 134,126 | 408,016 | 258,766 |
| Investing Cash Flow | $95,576 | $64,941 | $85,396 | $-394,845 | $-416,342 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,208 | 2,048 | 1,265 | 11,827 | 8,408 |
| Common Stock Repurchased | -50,000 | -50,000 | -37,526 | N/A | N/A |
| Other Financing Activity | -6,346 | -3,114 | -1,313 | 32,190 | 33,660 |
| Financing Cash Flow | $-54,138 | $-51,066 | $-37,574 | $44,017 | $42,068 |
| Beginning Cash Position | 71,308 | 71,308 | 71,308 | 495,729 | 495,729 |
| End Cash Position | 26,295 | 35,206 | 94,562 | 71,308 | 58,547 |
| Net Cash Flow | $-45,013 | $-36,102 | $23,254 | $-424,421 | $-437,182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,451 | -49,977 | -24,568 | -73,593 | -62,908 |
| Capital Expenditure | -527 | -365 | -175 | -358 | -183 |
| Free Cash Flow | -86,978 | -50,342 | -24,743 | -73,951 | -63,091 |